Alfonso Quintas Cardama - Jan 24, 2024 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role
Chief Medical Officer
Signature
/s/ Michael LaCascia, Attorney-in-Fact for Alfonso Quintas-Cardama
Stock symbol
FHTX
Transactions as of
Jan 24, 2024
Transactions value $
$183,600
Form type
4
Date filed
1/25/2024, 04:04 PM
Previous filing
Sep 13, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FHTX Stock Option (right to buy) Award $184K +60K $3.06 60K Jan 24, 2024 Common Stock 60K $3.06 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 25% of the underlying shares of common stock on January 24, 2025, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter.